These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7521940)

  • 21. [Nimodipine in ischemic cerebropathy].
    Di Lascio G; Salvini S
    Clin Ter; 1993 Feb; 142(2):123-6. PubMed ID: 8472525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nimodipine in acute ischemic stroke: a double-blind controlled study.
    Paci A; Ottaviano P; Trenta A; Iannone G; De Santis L; Lancia G; Moschini E; Carosi M; Amigoni S; Caresia L
    Acta Neurol Scand; 1989 Oct; 80(4):282-6. PubMed ID: 2683557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized double-blind controlled study of nimodipine in acute cerebral ischemic stroke.
    Nag D; Garg RK; Varma M
    Indian J Physiol Pharmacol; 1998 Oct; 42(4):555-8. PubMed ID: 10874361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute effects of nimodipine on the cerebral blood flow and intracranial pressure.
    Gaab MR; Haubitz I; Brawanski A; Korn A; Czech T
    Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():93-9. PubMed ID: 4010872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of nimodipine on cerebral infarcts and outcome after aneurysmal subarachnoid hemorrhage and surgery.
    Ohman J; Servo A; Heiskanen O
    J Neurosurg; 1991 Jan; 74(1):8-13. PubMed ID: 1984511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatosensory evoked potentials quantify clinical improvement of cerebral vasospasm after intravenous administration of nimodipine.
    Lipschitz R; Davidson K; Strugo V
    S Afr Med J; 1988 Oct; 74(8):403-5. PubMed ID: 3187819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intravenous nimodipine in the treatment of cerebral vasospasm following subarachnoid hemorrhage caused by aneurysm rupture: a comparative multicenter study].
    Desbordes JM; Ades PE; Guggiari M
    Agressologie; 1989 Jun; 30(7):438-40. PubMed ID: 2683824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of nimodipine (Nimotop-Bayer) in patients with chronic ischemic cerebral vasculopathies. Twenty-eight case reports.
    Politi GC; Romanini BM; Belloli PA; Rossi A; Bellaviti N; Pucci C; Ferro C
    Panminerva Med; 1990; 32(2):85-7. PubMed ID: 2250979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.
    Lancet; 1997 May; 349(9065):1569-81. PubMed ID: 9174558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nimodipine in ischemic stroke.
    Gelmers HJ
    Clin Neuropharmacol; 1987 Oct; 10(5):412-22. PubMed ID: 3332613
    [No Abstract]   [Full Text] [Related]  

  • 32. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of epilepsy partialis continuans with intravenous nimodipine. Report of two cases.
    Brandt L; Säveland H; Ljunggren B; Andersson KE
    J Neurosurg; 1988 Dec; 69(6):949-50. PubMed ID: 3142973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The nimodipine therapy of acute focal cerebral ischemia (minor stroke). A clinical study with an assessment of regional cerebral blood flow by SPECT].
    Rosselli A; Landini G; Castagnoli A; Vannucchi L; Mugnaini C; Calacoci S; Regoli G; Francesconi A; Turchi A; Agostino I
    Recenti Prog Med; 1992 Feb; 83(2):85-8. PubMed ID: 1502426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease.
    Langley MS; Sorkin EM
    Drugs; 1989 May; 37(5):669-99. PubMed ID: 2663415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on calcium antagonists in cerebrovascular diseases.
    Toni D; Frontoni M; Argentino C; Sacchetti ML; De Michele M; Fieschi C
    J Cardiovasc Pharmacol; 1991; 18 Suppl 8():S10-4. PubMed ID: 1726729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical experiences with nimodipine treatment in patients after SAH and aneurysm surgery.
    Wroński J; Abraszko R; Berny W; Mierzwa J
    Zentralbl Neurochir; 1990; 51(1):21-3. PubMed ID: 2275300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The calcium entry blocker nimodipine improves the quality of life of patients operated on for cerebral aneurysms. A 5-year follow-up analysis.
    Kostron H; Twerdy K; Grunert V
    Neurochirurgia (Stuttg); 1988 Sep; 31(5):150-3. PubMed ID: 3231282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A preliminary open trial with nimodipine in patients with cognitive impairment and leukoaraiosis.
    Pantoni L; Carosi M; Amigoni S; Mascalchi M; Inzitari D
    Clin Neuropharmacol; 1996 Dec; 19(6):497-506. PubMed ID: 8937788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex and Hemisphere - A Neglected, Nature-Determined Relationship in Acute Ischemic Stroke.
    Hametner C; Ringleb P; Kellert L
    Cerebrovasc Dis; 2015; 40(1-2):59-66. PubMed ID: 26184600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.